Today: 3 July 2026
Browse Category

NASDAQ:FER 20 December 2025 - 21 December 2025

Ferrovial SE Stock (NASDAQ: FER) Outlook: Nasdaq-100 Entry, €800 Million Buyback and Analyst Forecasts (Dec. 21, 2025)

Ferrovial SE Stock (NASDAQ: FER) Outlook: Nasdaq-100 Entry, €800 Million Buyback and Analyst Forecasts (Dec. 21, 2025)

Ferrovial SE stock is heading into a potentially volatile—and headline-heavy—week. The infrastructure group is set to join the Nasdaq-100 before the U.S. market opens on Monday, December 22, 2025, becoming the first IBEX 35 constituent to do so, while also rolling out a fresh €800 million share repurchase program and paying an additional holiday-season cash dividend. Cinco Días+3Reuters+3Nasdaq+3 For investors, the near-term question is simple: are these catalysts still “fuel,” or mostly “fireworks” after a big 2025 rally? The longer-term question is harder and more interesting: can Ferrovial keep compounding value from its North American toll-road portfolio and airport pipeline while maintaining disciplined capital allocation?
21 December 2025
·
Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

Ferrovial SE Stock (NASDAQ: FER) News and Forecasts for Dec. 20, 2025: Nasdaq-100 Entry, €800M Buyback, Dividend, and the 2026 Outlook

December 20, 2025 — Ferrovial SE is ending the week in a very different universe than most “infrastructure” stocks: on Monday, December 22, 2025, the company is set to join the Nasdaq-100, a club better known for megacap tech than toll roads. Reuters+1 That index milestone lands alongside two shareholder-friendly moves that help explain why Ferrovial stock has been under an unusually bright spotlight in December: a new €800 million share repurchase program and a cash dividend scheduled to be paid from December 22. PR Newswire+1
20 December 2025
··

Stock Market Today

  • Asahi Kasei (TSE:3407) wraps up ¥17.86bn buyback, highlights pharma tech scale-up
    July 3, 2026, 4:32 PM EDT. Asahi Kasei (TSE:3407) finished a ¥17.86 billion buyback, taking in 0.75% of its shares and signaling a focus on returns for shareholders. Peptistar has now launched Asahi Kasei's FO-MD system at the plant level, putting its pharmaceutical concentration tech into real-world production. This push could drive earnings through healthcare and process solutions, adding to its main battery and hydrogen businesses. Some risks remain for executing FO-MD and AK1940 at scale. The stock has moved up, but some see valuation still lagging-with fair value estimates pointing to a possible double from here. The story here is tighter capital discipline and a bigger bet on new technology.
Go toTop